The pathogenesis of CML involves the constitutive activation of the BCR-ABL tyrosine kinase, which governs malignant disease by activating multiple signal transduction pathways. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.